Cite this article
336
Downloads
15
Citations
354
Views
Announcements
Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.
Review
A review of maternally inherited diabetes and deafness
Show Less
1
Institute for Integrated Traditional and WesternMedicine, the Second Affiliated Hospital of Xingtai Medical College, Xingtai,054000, Hebei Province, China
2
Department of Health, Hotan Detachment of the Xinjiang Armed Police Corps, Hotan 848011, Xinjiang Uygur Autonomous Region, China
Front. Biosci. (Landmark Ed) 2014, 19(5), 777–782;
https://doi.org/10.2741/4244
Published: 1 January 2014
(This article belongs to the Special Issue Cellular immunology and stem cell biology)
Abstract
Maternally inherited diabetes and deafness (MIDD), a mitochondrial disease first described in 1992, results from the mitochondrial DNA mutation and affects up to 1% of the patients with diabetes. This review discusses the biomedical mechanisms of MIDD patients; summarizes the recent improvement of clinical and genetic diagnosis of MIDD; outlines the advances of the clinical management of these patients and their families.
Keywords
MIDD
NIDDM
mtTFA
RFLP
ACE-I
Review